MACROGEN Inc.
Shinmunno1ga, Chongno-gu
Seoul City
11
Tel: 82-02-740-8959
Website: http://www.macrogen.com/
Email: webmaster@macrogen.com
42 articles with MACROGEN Inc.
-
Macrogen Approved for Export of its COVID-19 Test Kit
5/20/2020
The Korean biotech company Macrogen (CEO Sukang Lee) (KOSDAQ: 038290), announced that it obtained export approval for COVID-19 test kit 'Axen TM COVID-19 RT' from the Ministry of Food and Drug Safety (MFDS) on the 18 th.
-
Now, Get A Free Knock-out Mouse: The Improved Sperm-freezing Technology Enables Macrogen to Open the Overseas Genetically-Engineered Mice Market
3/2/2020
Macrogen, the Korean precision medicine biotech company, is hosting a ‘Now, Get A Free Knock-out Mouse!’ event on a first-come, first-served basis.
-
Macrogen Signs License and Supply Agreement with Thermo Fisher Scientific
1/13/2020
Kap-Seok Yang, CEO of Macrogen, announced on January 13 that the company has signed a strategic License and Supply Agreement with Thermo Fisher Scientific.
-
Macrogen: Successful Construction of the Largest Northeast Asian Reference Panel
12/2/2019
Reference panel expected to contribute to discover the Northeast Asian specific illness-related genes, and to develop tailored diagnosis method
-
The gene sequencing industry has really taken off in the years since the Human Genome Project. Look at these best genome sequencing companies in the world.
-
Psomagen and Macrogen Granted U.S. Patent for Blockchain Data-sharing Technology
9/17/2019
Patent granted for blockchain technology for data transaction brokerage and sharing between data providers and users
-
Macrogen Announces Strategic Investment in Australian Microbiome Company, Microba
6/12/2019
Share subscription agreement of 4.1million AUD with Microba
-
Macrogen Receives GCLP Accreditation
5/28/2019
The precision medicine and biotechnology company, Macrogen announced on May 20 that it received GCLP accreditation from the Ministry of Food and Drug Safety in Korea.
-
Macrogen and Exosome Plus to Jointly Develop Exosome-based Diagnostic and Treatment Solutions
4/24/2019
Contract signed for Macrogen to become the exclusive buyer of ‘Exosome Plus’ high-efficiency exosome isolation kit, ‘Exo2DTM’
-
NRGene and Macrogen Launch Ultra-High-Density SNP Genotyping Service
1/12/2019
ArrayMAGIC is designed to provide convenient, cost-effective, and high-resolution genotyping
-
Macrogen Becomes the First Clinical Lab in Korea to Receive CLIA Accreditation
12/20/2018
NGS labs in Seoul headquarters and Bundang Precision Medicine Center become the first in Korea to receive CLIA accreditation
-
Macrogen Receives CAP Accreditation in Two Clinical Laboratories in Korea
8/13/2018
NGS Clinical Laboratories in Seoul headquarters and Bundang Precision Medicine Center Simultaneously Received the CAP Accreditation
-
Macrogen Establishes Overseas Corporation in Singapore to Focus on Southeast Asian Market in Earnest
6/5/2018
Macrogen, Inc. announced on June 5 that it has established Macrogen Asia Pacific Pte. Ltd., a subsidiary in Singapore.
-
Macrogen's Clinical NGS Laboratory Receives CAP Accreditation
11/15/2017
The accreditation was based on results of a recent on-site inspection as part of the CAP’s Accreditation Programs.
-
MACROGEN Established Its Branch In Spain, Strengthening Localization Service In Europe
9/5/2017
-
MACROGEN Launches Special Promotion On Exome Sequencing To Celebrate Their 20th Anniversary
6/2/2017
-
MACROGEN Leads Precision Medicine By Advancing The Realization Of The "$100 Genome Age"
3/28/2017
-
MACROGEN Launches "Easybox", A Premium Temperature-Controlled Package
9/13/2016
-
MACROGEN Launches Famplan Genetic Carrier Testing, And ABOOBA Genetic Test For Newborns
5/16/2016
-
MACROGEN And National Cancer Center Korea Sign Business Agreement For Joint Research Into Genome Information-Based Precision Medicine With Cancer Patients
4/27/2016